Background Treatment of severely ill COVID-19 patients requires simultaneous management
of oxygenation and inflammation without compromising viral clearance. While multiple …

Background: Tocilizumab has been proposed as an effective treatment for severe COVID-19.
We aimed to investigate whether tocilizumab administration is associated with increased …

As the healthcare response to the COVID-19 pandemic continues, providing enhanced
protection to frontline healthcare personnel exposed to aerosolized infectious material is …

The challenge of treating severely ill COVID-19 patients is particularly great due to the need
to simultaneously manage oxygenation and the inflammatory state without compromising …

Background: acute Cytomegalovirus (CMV) infection in the immunocompetent usually
asymptomatic or may present as a mononucleosis syndrome, but sometimes it is present as colitis, …

Facing the rapidly spreading novel coronavirus disease (COVID-19), evidence to inform
decision-making at both the clinical and policy-making level is highly needed. Based on the …

Background T and B cell receptor (TCR, BCR) repertoires constitute the foundation of
adaptive immunity. Adaptive immune receptor repertoire sequencing (AIRR-seq) is a common …

The adaptive immune system is a natural diagnostic sensor and therapeutic. It recognizes
threats earlier than clinical symptoms manifest and neutralizes antigens with exquisite …

Simple Summary Hyperglycosylated cancer cells are often decorated with abundant sialic
acids, which are recognized by Sialic acid binding immunoglobulin type lectins (Siglecs) …

Aims Chimeric Antigen Receptor-T (CAR-T) cell infusion is a rapidly evolving antitumor
therapy; however, cardiovascular (CV) complications, likely associated with cytokine release …